Business Description
Humana Inc
NAICS : 621610
SIC : 6324
ISIN : US4448591028
Share Class Description:
FRA:HUM: Ordinary SharesCompare
Compare
Traded in other countries / regions
HUM.USA0J6Z.UKHUM.MexicoH1UM34.BrazilHUM.Germany IPO Date
1971-05-18Description
Humana is one of the largest private health insurers in the us with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.43 | |||||
| Equity-to-Asset | 0.33 | |||||
| Debt-to-Equity | 0.77 | |||||
| Debt-to-EBITDA | 3.24 | |||||
| Interest Coverage | 5.16 | |||||
| Piotroski F-Score | 3/9 | |||||
| Beneish M-Score | -2.51 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 13.8 | |||||
| 3-Year EBITDA Growth Rate | -2.3 | |||||
| 3-Year EPS without NRI Growth Rate | 1 | |||||
| 3-Year FCF Growth Rate | -12 | |||||
| 3-Year Book Growth Rate | 7.7 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 3.79 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 51.31 | |||||
| 9-Day RSI | 47.47 | |||||
| 14-Day RSI | 43.49 | |||||
| 6-1 Month Momentum % | 1.18 | |||||
| 12-1 Month Momentum % | -41.12 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.36 | |||||
| Dividend Payout Ratio | 0.18 | |||||
| 3-Year Dividend Growth Rate | 12.3 | |||||
| Forward Dividend Yield % | 1.36 | |||||
| 5-Year Yield-on-Cost % | 2.43 | |||||
| 3-Year Average Share Buyback Ratio | 1.7 | |||||
| Shareholder Yield % | 3.26 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Net Margin % | 1.53 | |||||
| FCF Margin % | -4.44 | |||||
| ROE % | 10.33 | |||||
| ROA % | 3.3 | |||||
| ROIC % | 8.64 | |||||
| 3-Year ROIIC % | -6.53 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 19 | |||||
| Forward PE Ratio | 13.53 | |||||
| PE Ratio without NRI | 13.73 | |||||
| Shiller PE Ratio | 13.71 | |||||
| PEG Ratio | 1.3 | |||||
| PS Ratio | 0.29 | |||||
| PB Ratio | 1.92 | |||||
| Price-to-Tangible-Book | 4.51 | |||||
| EV-to-EBIT | 13.21 | |||||
| EV-to-Forward-EBIT | 12.16 | |||||
| EV-to-EBITDA | 10.03 | |||||
| EV-to-Forward-EBITDA | 9.17 | |||||
| EV-to-Revenue | 0.36 | |||||
| EV-to-Forward-Revenue | 0.35 | |||||
| EV-to-FCF | -7.91 | |||||
| Price-to-Projected-FCF | 0.67 | |||||
| Price-to-DCF (Earnings Based) | 0.52 | |||||
| Price-to-Median-PS-Value | 0.44 | |||||
| Price-to-Graham-Number | 1.66 | |||||
| Earnings Yield (Greenblatt) % | 7.57 | |||||
| FCF Yield % | -15.76 | |||||
| Forward Rate of Return (Yacktman) % | 11.82 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Humana Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 103,708.785 | ||
| EPS (TTM) (€) | 13.076 | ||
| Beta | 0.12 | ||
| Volatility % | 30.02 | ||
| 14-Day RSI | 43.49 | ||
| 14-Day ATR (€) | 6.415814 | ||
| 20-Day SMA (€) | 234.46 | ||
| 12-1 Month Momentum % | -41.12 | ||
| 52-Week Range (€) | 191 - 493.9 | ||
| Shares Outstanding (Mil) | 120.41 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Humana Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Humana Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Humana Inc Frequently Asked Questions
What is Humana Inc(FRA:HUM)'s stock price today?
The current price of FRA:HUM is €241.00. The 52 week high of FRA:HUM is €493.90 and 52 week low is €191.00.
When is next earnings date of Humana Inc(FRA:HUM)?
The next earnings date of Humana Inc(FRA:HUM) is 2025-01-24 Est..
Does Humana Inc(FRA:HUM) pay dividends? If so, how much?
The Dividend Yield %  of Humana Inc(FRA:HUM) is 1.36% (As of Today), Highest Dividend Payout Ratio of Humana Inc(FRA:HUM) was 0.19. The lowest was 0.1. And the median was 0.14. The  Forward Dividend Yield % of Humana Inc(FRA:HUM) is 1.36%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers